| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1993 | 2006 | ||||||||
|
MCC regulator of WNT signaling pathway | 0.568 | 0.731 | 4.7E-16 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1993 | 2012 | ||||||||
|
NME/NM23 nucleoside diphosphate kinase 1 | 0.443 | 0.808 | 3.2E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1993 | 2001 | ||||||||
|
mucin 1, cell surface associated | 0.384 | 0.885 | 1.9E-02 |
|
disease | 0.100 | None | 1.000 | 42 | 2 | 1994 | 2019 | ||||||||
|
mucin 4, cell surface associated | 0.506 | 0.769 | 2.8E-54 |
|
disease | 0.100 | None | 0.970 | 33 | 1 | 1994 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.100 | None | 0.875 | 32 | 0 | 1994 | 2020 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 1994 | 2020 | ||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.090 | None | 0.889 | 9 | 0 | 1994 | 2018 | ||||||||
|
mucin 2, oligomeric mucus/gel-forming | 0.486 | 0.808 | 9.4E-10 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1994 | 2019 | ||||||||
|
DCC netrin 1 receptor | 0.471 | 0.808 | 0.99 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1994 | 2001 | ||||||||
|
islet amyloid polypeptide | 0.507 | 0.808 | 3.2E-03 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1994 | 2011 | ||||||||
|
heparin binding EGF like growth factor | 0.520 | 0.769 | 7.6E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
MAGE family member H1 | 0.743 | 0.308 | 0.23 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.600 | None | 0.980 | 102 | 3 | 1995 | 2019 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.400 | None | 0.986 | 73 | 1 | 1995 | 2019 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.100 | None | 0.944 | 36 | 1 | 1995 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.100 | None | 1.000 | 30 | 0 | 1995 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.100 | None | 0.950 | 20 | 0 | 1995 | 2019 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 1995 | 2019 | ||||||||
|
fibronectin 1 | 0.365 | 0.962 | 1.4E-03 |
|
disease | 0.090 | None | 0.889 | 9 | 0 | 1995 | 2019 | ||||||||
|
TIMP metallopeptidase inhibitor 1 | 0.380 | 0.885 | 0.50 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1995 | 2018 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1995 | 2019 | ||||||||
|
cyclin dependent kinase 2 | 0.456 | 0.692 | 0.61 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1995 | 2009 | ||||||||
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1995 | 2019 | ||||||||
|
selectin E | 0.447 | 0.808 | 7.9E-10 |
|
disease | 0.040 | None | 0.750 | 4 | 2 | 1995 | 2017 |